Skip to main content
UniHealth

Doctor search

Beahwa Yeoh, NP

Nurse Practitioner · San Jose

NPI 1588621577

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
20 years
Graduated 2006

Offices

1 location · County of Santa Clara · 1,000 clinicians in this group

Looking this up.

Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Beahwa Yeoh’s office at (408) 885-5000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A16068 · Cancelled

Licence status: Cancelled · since 1954 · Ludwig-Maximilians-University of Munich Faculty of Medicine.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend it
    Overall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Santa Clara Valley Medical Center
SSI - Colon SurgeryInfections2.572WorseOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.563BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.256BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.369BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.25 (0.3 to 2.2) · 1,535 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.07 (0.76 to 1.38)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths214.59 (167.38 to 261.8) · 108 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6 · 141 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.2 · 124 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.3 · 501 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.9 · 653 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 348 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 4,502 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.24 (0.04 to 0.43) · 9,014 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.34 (0.15 to 0.52) · 9,216 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.54 (2.51 to 6.58) · 1,421 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.54 (0 to 3.2) · 288 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,446 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.61 (4.09 to 19.14) · 294 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.29 (3.39 to 11.2) · 299 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.9 (0.45 to 3.36) · 333 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.23 (0 to 0.78) · 7,538 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths5.4 · 94 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.735No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections2.573No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.6 · 185 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 951 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits56.3 · 128 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits6.4 · 644 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits1.3 · 699 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.3 · 921 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (3.9 to 8.1) · 226 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.6 (9.4 to 16.5) · 226 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.4 · 94 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.4 · 54 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.3 · 242 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.2 (9.9 to 17.4) · 702 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.4) · 195 casesNo differentJan 2024 – Dec 2024

What patients said (4,032 patients answered, 29% of those asked)

Patient survey stars by topic at Santa Clara Valley Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information2
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Santa Clara Valley Medical Center
Room was "always" clean70%
Nurses "always" communicated well73%
Doctors "always" communicated well76%
Staff "always" explained57%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications71%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully69%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital70%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms83%

Medicaid work

$4,823 in 2024

Medicaid paid $4,823 for 314 billed services this clinician did in 2024, up to 23 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension23$1,284
Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique17$676
Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique17$656
Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result23$373
IAAD IA HEPATITIS B SURFACE ANTIGEN23$269
HEPATITIS C ANTIBODY16$259
Antibody; varicella-zoster16$227
Assay for total hepatitis B core antibody (HBcAb)16$219
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count23$203
Hepatitis B surface antibody (HBsAb)16$195
TREPONEMA PALLIDUM16$146
HEPATIC FUNCTION PANEL23$133
Medicaid work by year
20243141623$4,823
20231,4641933$22,106
20223101722$13,507
20211,3042660$108,765
202063220$17,950
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension106$5,917
Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique69$2,744
Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique69$2,663
Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result111$2,249
IAAD IA HEPATITIS B SURFACE ANTIGEN111$1,299
HEPATITIS C ANTIBODY65$1,052
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count108$953
Assay for total hepatitis B core antibody (HBcAb)68$929
Antibody; varicella-zoster65$921
Hepatitis B surface antibody (HBsAb)67$815
HEPATIC FUNCTION PANEL111$703
TREPONEMA PALLIDUM69$629

2022

Largest Medicaid services in 2022
Clinic visit/encounter, all-inclusive21$10,601
Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension17$949
Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result35$554
IAAD IA HEPATITIS B SURFACE ANTIGEN18$211
HEPATITIS C ANTIBODY13$210
TREPONEMA PALLIDUM23$203
Antibody; varicella-zoster12$170
Assay for total hepatitis B core antibody (HBcAb)12$164
Hepatitis B surface antibody (HBsAb)12$146
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count16$141
HEPATIC FUNCTION PANEL17$102
Creatinine; blood30$30

2021

Largest Medicaid services in 2021
Clinic visit/encounter, all-inclusive203$98,819
Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension51$2,847
Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result99$1,563
Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique25$994
Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique25$965
IAAD IA HEPATITIS B SURFACE ANTIGEN52$608
TREPONEMA PALLIDUM59$517
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count49$432
HEPATITIS C ANTIBODY21$340
HEPATIC FUNCTION PANEL50$313
Assay for total hepatitis B core antibody (HBcAb)20$273
Antibody; varicella-zoster19$269

2020

Largest Medicaid services in 2020
Clinic visit/encounter, all-inclusive39$17,950
Short return visit24$0

Drugs they prescribed that Part D paid

$181,151

Pharmacies billed $181,151 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 408) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.

129 generic and 261 brand-name prescriptions · $181,151 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ozempic55$48,992$891
Trulicity34$34,545$1,016
Jardiance51$28,918$567
Mounjaro13$13,181$1,014
Synjardy Xr18$9,570$532
See all 12 drugs
Every Part D drug this clinician prescribed
Ozempic55$48,992$891
Trulicity34$34,545$1,016
Jardiance51$28,918$567
Mounjaro13$13,181$1,014
Synjardy Xr18$9,570$532
Xigduo Xr13$7,133$549
Tradjenta14$5,734$410
Rifampin18$731$41
Ultra-Fine Short Pen Needle11$607$55
Metformin Hcl Er43$325$8
Isoniazid31$160$5
Pioglitazone13$51$4

Year by year

Part D prescribing by year
2024408470% (0)64%$181,151
2023532930% (0)55%$233,599
2022548750% (0)65%$252,135
2021415630% (0)60%$167,208
2020320460% (0)53%$118,542
2019237540% (0)34%$46,518
2018322880% (0)None$42,295
2017191690% (0)None$15,446
2016224810% (0)None$8,791
201565188NoneNone$28,928
201471476NoneNone$27,841
201348675None19%$22,034

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 10 drugs

Part D drugs prescribed in 2023
Trulicity98$109,941$1,122
Ozempic41$38,985$951
Synjardy Xr31$18,073$583
Jardiance21$13,183$628
Xigduo Xr12$6,818$568
Janumet Xr11$6,114$556
Rifampin55$3,774$69
Ultra-Fine Nano Pen Needle13$792$61
Isoniazid66$552$8
Metformin Hcl Er54$537$10

2022: 11 drugs

Part D drugs prescribed in 2022
Trulicity140$130,831$935
Jardiance63$33,214$527
Synjardy Xr37$20,584$556
Ozempic22$19,794$900
Rybelsus13$12,412$955
Basaglar Kwikpen U-10012$2,681$223
Rifampin36$2,426$67
Clotrimazole17$804$47
Metformin Hcl Er62$405$7
Isoniazid38$256$7
Lisinopril14$125$9

2021: 8 drugs

Part D drugs prescribed in 2021
Trulicity93$79,892$859
Jardiance61$33,184$544
Synjardy Xr26$13,749$529
Fiasp Flextouch11$1,200$109
Rifampin13$663$51
Clotrimazole12$646$54
Isoniazid51$368$7
Metformin Hcl Er71$262$4

2020: 7 drugs

Part D drugs prescribed in 2020
Jardiance43$25,605$595
Trulicity27$23,477$870
Synjardy Xr14$7,652$547
Clotrimazole13$229$18
Isoniazid34$228$7
Metformin Hcl Er22$86$4
Metformin29$76$3

2019: 7 drugs

Part D drugs prescribed in 2019
Jardiance17$8,200$482
Lantus Solostar15$3,469$231
Rifampin18$998$55
Isoniazid71$542$8
Metformin Hcl Er18$131$7
Glipizide12$94$8
Metformin14$43$3

2018: 6 drugs

Part D drugs prescribed in 2018
Trulicity19$13,900$732
Lantus Solostar29$7,603$262
Levemir Flextouch14$6,284$449
Novolog Flexpen12$4,361$363
Rifampin49$2,790$57
Isoniazid155$1,074$7

2017: 3 drugs

Part D drugs prescribed in 2017
Lantus Solostar18$4,021$223
Rifampin17$1,168$69
Isoniazid120$794$7

2016: 1 drug

Part D drugs prescribed in 2016
Isoniazid149$951$6

2015: 20 drugs

Part D drugs prescribed in 2015
Tamsulosin17$549$32
Pioglitazone12$549$46
Levothyroxine22$533$24
Atorvastatin26$276$11
Fluticasone Propionate18$257$14
Isoniazid34$243$7
Sertraline12$243$20
Simvastatin27$242$9
Metformin20$215$11
Hydrochlorothiazide25$152$6
Amlodipine Besylate20$147$7
Lisinopril30$140$5
Glipizide14$128$9
Gabapentin16$122$8
Famotidine17$119$7
Benazepril11$119$11
Ranitidine13$107$8
Alendronate11$82$7
Losartan14$53$4
Trazodone14$29$2

2014: 18 drugs

Part D drugs prescribed in 2014
Pioglitazone25$1,585$63
Voltaren11$737$67
Bupropion Hcl Sr13$480$37
Levothyroxine29$454$16
Metformin33$441$13
Simvastatin46$414$9
Atorvastatin16$382$24
Tamsulosin20$345$17
Fluticasone Propionate17$341$20
Lisinopril34$333$10
Amlodipine Besylate33$186$6
Gabapentin25$164$7
Glipizide21$156$7
Ranitidine21$130$6
Benazepril14$112$8
Sertraline19$108$6
Hydrochlorothiazide35$103$3
Ibuprofen19$77$4

2013: 10 drugs

Part D drugs prescribed in 2013
Lantus18$3,315$184
Levothyroxine36$405$11
Metformin33$351$11
Fluticasone Propionate12$320$27
Lisinopril36$239$7
Simvastatin18$191$11
Amlodipine Besylate20$158$8
Ranitidine12$99$8
Hydrochlorothiazide21$72$3
Ibuprofen15$59$4

Professional record

NPI
1588621577
Licence
CA 16068California A16068: Cancelled
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 363LF0000X (363LF0000X)
Mailing address
1333 Meridian Ave, San Jose, CA, 95125
NPI first listed
2006-04-26
NPI last updated
2009-02-24

This is when the NPI record was last certified, not a medical board exam.